MOLLY BENEDICT: Open Payments
NPI 1477288868 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,838 in 68 payments from 19 companies in 2025. Trend: 2023 $1,808 · 2024 $1,863 · 2025 $1,838
Food & beverage: $1,838
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $448 |
| Arcutis Biotherapeutics, Inc. | 6 | $227 |
| Regeneron Healthcare Solutions, Inc. | 5 | $186 |
| ABBVIE INC. | 9 | $171 |
| Galderma Laboratories, L.P. | 9 | $135 |
| Novartis Pharmaceuticals Corporation | 5 | $128 |
| Almirall LLC | 4 | $103 |
| Botanix SB Inc | 4 | $75 |
| Incyte Corporation | 3 | $70 |
| LEO Pharma Inc. | 3 | $58 |
Products named: DUPIXENT, Zoryve, SKYRIZI, Seysara, Rhapsido, SOFDRA, AKLIEF, OPZELURA.
Industry payments across GA — which companies pay providers there.
